Josep Tabernero

(President of ESMO)

Josep Tabernero holds MD and PhD degrees from the Universitat Autònoma de Barcelona, Spain, and he is currently Head of the Medical Oncology Department at the Vall d’Hebron University Hospital and Director of the Vall d’Hebron Institute of Oncology (VHIO). He is Principal Investigator of several Phase I pharmacodynamic studies and translational projects with tumour-directed targeted therapies and immune therapies.

Josep is also a member of the American Association for Cancer Research (AACR), and the American Society of Clinical Oncology (ASCO).